Trial Outcomes & Findings for Optimizing tDCS to Improve Dual Task Gait and Balance (NCT NCT04295798)
NCT ID: NCT04295798
Last Updated: 2025-01-30
Results Overview
Prior to testing, participants were outfitted with wireless biosensors, each containing a triaxial accelerometer, goniometer and magnetometer, on the low back and feet to record gait kinematics (Mobility Lab™, APDM Inc). Six 25-meter walking trials were completed pre and post tDCS. Two at a preferred speed while walking quietly (single task), two at a preferred speed while performing a cognitive task (dual task) and two fast walking trials. The cognitive task during the dual task condition was verbalized serial subtractions of 3's from a random three-digit number. The absolute change was then calculated using post-intervention dual task cost minus baseline dual task cost. The outcome was calculated by averaging the dual task costs of the four trials. Negative numbers demonstrate lower (i.e., better) dual task cost post intervention. The preferred Unit of Measure is unitless.
COMPLETED
NA
29 participants
Change from baseline to immediately post-tDCS, up to 60 minutes
2025-01-30
Participant Flow
Participant milestones
| Measure |
Crossover tDCS
On each visit, participants were randomly assigned to receive one of four different 20-minute tDCS interventions: Conventional tDCS, Optimized tDCS, Conventional Sham, and Optimized Sham.
|
|---|---|
|
Overall Study
STARTED
|
29
|
|
Overall Study
Conventional tDCS
|
29
|
|
Overall Study
Optimized tDCS
|
29
|
|
Overall Study
Conventional Sham
|
29
|
|
Overall Study
Optimized Sham
|
28
|
|
Overall Study
COMPLETED
|
28
|
|
Overall Study
NOT COMPLETED
|
1
|
Reasons for withdrawal
| Measure |
Crossover tDCS
On each visit, participants were randomly assigned to receive one of four different 20-minute tDCS interventions: Conventional tDCS, Optimized tDCS, Conventional Sham, and Optimized Sham.
|
|---|---|
|
Overall Study
Lost to Follow-up
|
1
|
Baseline Characteristics
Optimizing tDCS to Improve Dual Task Gait and Balance
Baseline characteristics by cohort
| Measure |
Four Interventions in a Cross-over Design
n=29 Participants
Each subject participated in four sessions of interventions in different days. Conventional tDCS: One 20-minute session of active transcranial direct current stimulation (tDCS) using large sponge electrodes targeting the left dorsolateral prefrontal cortex.
Optimized tDCS: One 20-minute session of active transcranial direct current stimulation (tDCS) using eight gel electrodes with placement and current parameters optimized to the cohort targeting the left dorsolateral prefrontal cortex.
Conventional Sham: One 20-minute session of inactive sham in which tDCS will be delivered via sponge electrodes for a short period of time before it is ramped down to zero for the remainder of the session.
Optimized Sham: One 20-minute session of active sham in which the Stimweaver optimization algorithm will be used with the objective of creating a null electric field on the target (left dlPFC) with the constraint that some gel electrodes deliver low-level currents that still induce cutaneous sensations.
|
|---|---|
|
Age, Continuous
|
75.8 years
STANDARD_DEVIATION 5.84 • n=5 Participants
|
|
Sex: Female, Male
Female
|
21 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
8 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
2 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
27 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
|
Body Mass Index (BMI)
|
27.64 kg/m^2
STANDARD_DEVIATION 4.70 • n=5 Participants
|
PRIMARY outcome
Timeframe: Change from baseline to immediately post-tDCS, up to 60 minutesPrior to testing, participants were outfitted with wireless biosensors, each containing a triaxial accelerometer, goniometer and magnetometer, on the low back and feet to record gait kinematics (Mobility Lab™, APDM Inc). Six 25-meter walking trials were completed pre and post tDCS. Two at a preferred speed while walking quietly (single task), two at a preferred speed while performing a cognitive task (dual task) and two fast walking trials. The cognitive task during the dual task condition was verbalized serial subtractions of 3's from a random three-digit number. The absolute change was then calculated using post-intervention dual task cost minus baseline dual task cost. The outcome was calculated by averaging the dual task costs of the four trials. Negative numbers demonstrate lower (i.e., better) dual task cost post intervention. The preferred Unit of Measure is unitless.
Outcome measures
| Measure |
Conventional tDCS
n=29 Participants
One 20-minute session of active tDCS using two 35 cm2 sponge electrodes targeting the left dlPFC.
|
Optimized tDCS
n=29 Participants
One 20-minute session of active tDCS using two 35 cm2 sponge electrodes targeting the left dlPFC.
|
Conventional Sham
n=29 Participants
One 20-minute session of inactive sham tDCS delivered via two sponge electrodes for a short period of time before it is ramped down to zero for the remainder of the session.
|
Optimized Sham
n=28 Participants
One 20-minute session of active sham in which the Stimweaver optimization algorithm will be used with the objective of creating a null electric field on the target left dlPFC with the constraint that some gel electrodes deliver low-level currents that still induce cutaneous sensations.
|
|---|---|---|---|---|
|
Absolute Change in Dual Task Cost to Gait Speed From Baseline to Immediately Post Intervention
|
-2.29 unitless
Standard Deviation 4.35
|
-3.88 unitless
Standard Deviation 2.77
|
0.06 unitless
Standard Deviation 4.71
|
-0.10 unitless
Standard Deviation 3.21
|
PRIMARY outcome
Timeframe: Change from baseline to immediately post-tDCS, up to 60 minutesPostural sway speed was assessed by measuring standing postural sway (ie., center-of pressure fluctuations) during six, 45-second trials of standing with eyes open (single task), eyes closed, or performing a cognitive task (dual task standing) on a stationary force platform (Kistler, Amherst, NY). The cognitive task was verbalized serial subtractions of 3's from a random three-digit number between 200 and 999. Participant responses during each trial were recorded. The absolute change was then calculated using post-intervention dual task cost minus baseline dual task cost. The outcome was obtained by averaging the dual task costs of the four trials. Negative numbers demonstrate lower (i.e., better) dual task cost post intervention. The preferred Unit of Measure is unitless.
Outcome measures
| Measure |
Conventional tDCS
n=29 Participants
One 20-minute session of active tDCS using two 35 cm2 sponge electrodes targeting the left dlPFC.
|
Optimized tDCS
n=29 Participants
One 20-minute session of active tDCS using two 35 cm2 sponge electrodes targeting the left dlPFC.
|
Conventional Sham
n=29 Participants
One 20-minute session of inactive sham tDCS delivered via two sponge electrodes for a short period of time before it is ramped down to zero for the remainder of the session.
|
Optimized Sham
n=28 Participants
One 20-minute session of active sham in which the Stimweaver optimization algorithm will be used with the objective of creating a null electric field on the target left dlPFC with the constraint that some gel electrodes deliver low-level currents that still induce cutaneous sensations.
|
|---|---|---|---|---|
|
Absolute Change in Dual Task Cost to Standing Postural Sway Speed From Baseline to Immediately Post Intervention
|
-7.66 unitless
Standard Deviation 10.38
|
-5.97 unitless
Standard Deviation 11.03
|
26.88 unitless
Standard Deviation 9.83
|
5.06 unitless
Standard Deviation 11.03
|
SECONDARY outcome
Timeframe: Change from baseline to immediately post-tDCS, up to 60 minutesStride time variability is a measure of how consistent limb movements are during walking and is expressed as the coefficient of variation. Prior to testing, participants were outfitted with wireless biosensors, each containing a triaxial accelerometer, goniometer and magnetometer to record gait kinematics (Mobility Lab™, APDM Inc). Six 25-meter walking trials were completed. Two at a preferred speed while walking quietly (single task), two at a preferred speed while performing a cognitive task (dual task) and two fast walking trials. The cognitive task during the dual task condition was verbalized serial subtractions of 3's. The absolute change was then calculated using post-intervention dual task cost minus baseline dual task cost. Negative numbers demonstrate lower (i.e., better) dual task cost post intervention. The preferred Unit of Measure is unitless.
Outcome measures
| Measure |
Conventional tDCS
n=29 Participants
One 20-minute session of active tDCS using two 35 cm2 sponge electrodes targeting the left dlPFC.
|
Optimized tDCS
n=29 Participants
One 20-minute session of active tDCS using two 35 cm2 sponge electrodes targeting the left dlPFC.
|
Conventional Sham
n=29 Participants
One 20-minute session of inactive sham tDCS delivered via two sponge electrodes for a short period of time before it is ramped down to zero for the remainder of the session.
|
Optimized Sham
n=28 Participants
One 20-minute session of active sham in which the Stimweaver optimization algorithm will be used with the objective of creating a null electric field on the target left dlPFC with the constraint that some gel electrodes deliver low-level currents that still induce cutaneous sensations.
|
|---|---|---|---|---|
|
Absolute Change in Dual Task Cost to Stride Time Variability From Baseline to Immediately Post Intervention
|
-9.86 unitless
Standard Deviation 53.03
|
-24.96 unitless
Standard Deviation 27.96
|
4.29 unitless
Standard Deviation 34.43
|
0.84 unitless
Standard Deviation 33.18
|
SECONDARY outcome
Timeframe: Change from baseline to immediately post-tDCS, up to 60 minutesPrior to testing, participants were outfitted with wireless biosensors, each containing a triaxial accelerometer, goniometer and magnetometer, on the low back and feet to record gait kinematics (Mobility Lab™, APDM Inc). Six 25-meter walking trials were completed pre and post tDCS. Two at a preferred speed while walking quietly (single task). The absolute change from baseline to immediately post intervention was calculated by averaging the single task gait speeds (m/s) pre and post.
Outcome measures
| Measure |
Conventional tDCS
n=29 Participants
One 20-minute session of active tDCS using two 35 cm2 sponge electrodes targeting the left dlPFC.
|
Optimized tDCS
n=29 Participants
One 20-minute session of active tDCS using two 35 cm2 sponge electrodes targeting the left dlPFC.
|
Conventional Sham
n=29 Participants
One 20-minute session of inactive sham tDCS delivered via two sponge electrodes for a short period of time before it is ramped down to zero for the remainder of the session.
|
Optimized Sham
n=28 Participants
One 20-minute session of active sham in which the Stimweaver optimization algorithm will be used with the objective of creating a null electric field on the target left dlPFC with the constraint that some gel electrodes deliver low-level currents that still induce cutaneous sensations.
|
|---|---|---|---|---|
|
Absolute Change in Single Task Gait Speed From Baseline to Immediately Post Intervention
|
0.025 m/s
Standard Deviation 0.01
|
0.031 m/s
Standard Deviation 0.012
|
0.017 m/s
Standard Deviation 0.011
|
0.014 m/s
Standard Deviation 0.012
|
SECONDARY outcome
Timeframe: Change from baseline to immediately post-tDCS, up to 60 minutesPrior to testing, participants were outfitted with wireless biosensors, each containing a triaxial accelerometer, goniometer and magnetometer, on the low back and feet to record gait kinematics (Mobility Lab™, APDM Inc). Six 25-meter walking trials were completed pre and post tDCS. Two at a preferred speed while performing a cognitive task (dual task). The cognitive task during the dual task condition was verbalized serial subtractions of 3's from a random three-digit number between 200 and 999. Participant responses during each trial were recorded. The absolute change from baseline to immediately post intervention was calculated by averaging the dual task gait speeds (m/s) pre and post.
Outcome measures
| Measure |
Conventional tDCS
n=29 Participants
One 20-minute session of active tDCS using two 35 cm2 sponge electrodes targeting the left dlPFC.
|
Optimized tDCS
n=29 Participants
One 20-minute session of active tDCS using two 35 cm2 sponge electrodes targeting the left dlPFC.
|
Conventional Sham
n=29 Participants
One 20-minute session of inactive sham tDCS delivered via two sponge electrodes for a short period of time before it is ramped down to zero for the remainder of the session.
|
Optimized Sham
n=28 Participants
One 20-minute session of active sham in which the Stimweaver optimization algorithm will be used with the objective of creating a null electric field on the target left dlPFC with the constraint that some gel electrodes deliver low-level currents that still induce cutaneous sensations.
|
|---|---|---|---|---|
|
Absolute Change in Dual Task Gait Speed From Baseline to Immediately Post Intervention
|
0.046 m/s
Standard Deviation 0.086
|
0.042 m/s
Standard Deviation 0.048
|
-0.002 m/s
Standard Deviation 0.011
|
0.016 m/s
Standard Deviation 0.029
|
SECONDARY outcome
Timeframe: Change from baseline to immediately post-tDCS, up to 60 minutesStride time variability (STV) is a measure of how consistent limb movements are during walking. It's expressed as the coefficient of variation (CoV) and calculated from the mean and standard deviation of stride time. Prior to testing, participants were outfitted with wireless biosensors, each containing a triaxial accelerometer, goniometer and magnetometer, on the low back and feet to record gait kinematics (Mobility Lab™, APDM Inc). Six 25-meter walking trials were completed. Two at a preferred speed while walking quietly (single task). The absolute change from baseline to immediately post intervention was calculated by averaging the single task stride time variability pre and post.
Outcome measures
| Measure |
Conventional tDCS
n=29 Participants
One 20-minute session of active tDCS using two 35 cm2 sponge electrodes targeting the left dlPFC.
|
Optimized tDCS
n=29 Participants
One 20-minute session of active tDCS using two 35 cm2 sponge electrodes targeting the left dlPFC.
|
Conventional Sham
n=29 Participants
One 20-minute session of inactive sham tDCS delivered via two sponge electrodes for a short period of time before it is ramped down to zero for the remainder of the session.
|
Optimized Sham
n=28 Participants
One 20-minute session of active sham in which the Stimweaver optimization algorithm will be used with the objective of creating a null electric field on the target left dlPFC with the constraint that some gel electrodes deliver low-level currents that still induce cutaneous sensations.
|
|---|---|---|---|---|
|
Absolute Change in Single Task Stride Time Variability From Baseline to Immediately Post Intervention
|
-0.07 coefficient of variation
Standard Deviation 0.09
|
-0.04 coefficient of variation
Standard Deviation 0.09
|
-0.06 coefficient of variation
Standard Deviation 0.08
|
-0.03 coefficient of variation
Standard Deviation 0.09
|
SECONDARY outcome
Timeframe: Change from baseline to immediately post-tDCS, up to 60 minutesStride time variability (STV) is a measure of how consistent limb movements are during walking. It's expressed as the coefficient of variation (CoV) and calculated from the mean and standard deviation of stride time. Prior to testing, participants were outfitted with wireless biosensors, each containing a triaxial accelerometer, goniometer and magnetometer, on the low back and feet to record gait kinematics (Mobility Lab™, APDM Inc). Six 25-meter walking trials were completed. Two at a preferred speed while performing a cognitive task (dual task). The cognitive task during the dual task condition was verbalized serial subtractions of 3's from a random three-digit number between 200 and 999. Participant responses during each trial were recorded. The absolute change from baseline to immediately post intervention was calculated by averaging the dual task stride time variability pre and post.
Outcome measures
| Measure |
Conventional tDCS
n=29 Participants
One 20-minute session of active tDCS using two 35 cm2 sponge electrodes targeting the left dlPFC.
|
Optimized tDCS
n=29 Participants
One 20-minute session of active tDCS using two 35 cm2 sponge electrodes targeting the left dlPFC.
|
Conventional Sham
n=29 Participants
One 20-minute session of inactive sham tDCS delivered via two sponge electrodes for a short period of time before it is ramped down to zero for the remainder of the session.
|
Optimized Sham
n=28 Participants
One 20-minute session of active sham in which the Stimweaver optimization algorithm will be used with the objective of creating a null electric field on the target left dlPFC with the constraint that some gel electrodes deliver low-level currents that still induce cutaneous sensations.
|
|---|---|---|---|---|
|
Absolute Change in Dual Task Stride Time Variability From Baseline to Immediately Post Intervention
|
-0.27 coefficient of variation
Standard Deviation 1.04
|
-0.23 coefficient of variation
Standard Deviation 0.37
|
-0.16 coefficient of variation
Standard Deviation 0.89
|
-0.13 coefficient of variation
Standard Deviation 0.50
|
SECONDARY outcome
Timeframe: Change from baseline to immediately post-tDCS, up to 60 minutesPostural sway area was assessed by measuring postural sway elliptical area during six, 45-second trials of standing with eyes open (single task), eyes closed, or performing a cognitive task (dual task standing) on a stationary force platform (Kistler, Amherst, NY). The cognitive task was verbalized serial subtractions of 3's from a random three-digit number between 200 and 999. Participant responses during each trial were recorded. The absolute change was then calculated using post-intervention dual task cost minus baseline dual task cost. The outcome was obtained by averaging the dual task costs of the four trials. Negative numbers demonstrate lower (i.e., better) dual task cost post intervention. The preferred Unit of Measure is unitless.
Outcome measures
| Measure |
Conventional tDCS
n=29 Participants
One 20-minute session of active tDCS using two 35 cm2 sponge electrodes targeting the left dlPFC.
|
Optimized tDCS
n=29 Participants
One 20-minute session of active tDCS using two 35 cm2 sponge electrodes targeting the left dlPFC.
|
Conventional Sham
n=29 Participants
One 20-minute session of inactive sham tDCS delivered via two sponge electrodes for a short period of time before it is ramped down to zero for the remainder of the session.
|
Optimized Sham
n=28 Participants
One 20-minute session of active sham in which the Stimweaver optimization algorithm will be used with the objective of creating a null electric field on the target left dlPFC with the constraint that some gel electrodes deliver low-level currents that still induce cutaneous sensations.
|
|---|---|---|---|---|
|
Absolute Change in Dual Task Cost to Standing Postural Sway Area From Baseline to Immediately Post Intervention
|
-23.17 unitless
Standard Deviation 82.98
|
-3.18 unitless
Standard Deviation 59.23
|
21.45 unitless
Standard Deviation 71.17
|
-3.23 unitless
Standard Deviation 58.45
|
SECONDARY outcome
Timeframe: Change from baseline to immediately post-tDCS, up to 60 minutesPostural sway speed was assessed by measuring standing postural sway (ie., center-of pressure fluctuations) during two, 45-second trials of standing with eyes open (single task) on a stationary force platform (Kistler, Amherst, NY) pre and post intervention. The absolute change from baseline to immediately post intervention was calculated by averaging the single task postural sway speed (m/s) pre and post.
Outcome measures
| Measure |
Conventional tDCS
n=29 Participants
One 20-minute session of active tDCS using two 35 cm2 sponge electrodes targeting the left dlPFC.
|
Optimized tDCS
n=29 Participants
One 20-minute session of active tDCS using two 35 cm2 sponge electrodes targeting the left dlPFC.
|
Conventional Sham
n=29 Participants
One 20-minute session of inactive sham tDCS delivered via two sponge electrodes for a short period of time before it is ramped down to zero for the remainder of the session.
|
Optimized Sham
n=28 Participants
One 20-minute session of active sham in which the Stimweaver optimization algorithm will be used with the objective of creating a null electric field on the target left dlPFC with the constraint that some gel electrodes deliver low-level currents that still induce cutaneous sensations.
|
|---|---|---|---|---|
|
Absolute Change in Single Task Postural Sway Speed From Baseline to Immediately Post Intervention
|
0.013 m/s
Standard Deviation 0.023
|
-0.018 m/s
Standard Deviation 0.023
|
-0.028 m/s
Standard Deviation 0.023
|
0.0078 m/s
Standard Deviation 0.024
|
SECONDARY outcome
Timeframe: Change from baseline to immediately post-tDCS, up to 60 minutesPostural sway speed was assessed by measuring standing postural sway (ie., center-of pressure fluctuations) during two, 45-second trials of standing with eyes open while performing a cognitive task (dual task) on a stationary force platform (Kistler, Amherst, NY) pre and post intervention. The cognitive task was verbalized serial subtractions of 3's from a random three-digit number between 200 and 999. Participant responses during each trial were recorded. The absolute change from baseline to immediately post intervention was calculated by averaging the dual task postural sway speed (m/s) pre and post.
Outcome measures
| Measure |
Conventional tDCS
n=29 Participants
One 20-minute session of active tDCS using two 35 cm2 sponge electrodes targeting the left dlPFC.
|
Optimized tDCS
n=29 Participants
One 20-minute session of active tDCS using two 35 cm2 sponge electrodes targeting the left dlPFC.
|
Conventional Sham
n=29 Participants
One 20-minute session of inactive sham tDCS delivered via two sponge electrodes for a short period of time before it is ramped down to zero for the remainder of the session.
|
Optimized Sham
n=28 Participants
One 20-minute session of active sham in which the Stimweaver optimization algorithm will be used with the objective of creating a null electric field on the target left dlPFC with the constraint that some gel electrodes deliver low-level currents that still induce cutaneous sensations.
|
|---|---|---|---|---|
|
Absolute Change in Dual Task Postural Sway Speed From Baseline to Immediately Post Intervention
|
-0.0056 m/s
Standard Deviation 0.016
|
-0.0029 m/s
Standard Deviation 0.018
|
0.063 m/s
Standard Deviation 0.017
|
-0.0001 m/s
Standard Deviation 0.018
|
SECONDARY outcome
Timeframe: Change from baseline to immediately post-tDCS, up to 60 minutesPostural sway area was assessed by measuring postural sway elliptical area during two, 45-second trials of standing with eyes open (single task) on a stationary force platform (Kistler, Amherst, NY) pre and post intervention. The absolute change from baseline to immediately post intervention was calculated by averaging the single task postural sway area pre and post.
Outcome measures
| Measure |
Conventional tDCS
n=29 Participants
One 20-minute session of active tDCS using two 35 cm2 sponge electrodes targeting the left dlPFC.
|
Optimized tDCS
n=29 Participants
One 20-minute session of active tDCS using two 35 cm2 sponge electrodes targeting the left dlPFC.
|
Conventional Sham
n=29 Participants
One 20-minute session of inactive sham tDCS delivered via two sponge electrodes for a short period of time before it is ramped down to zero for the remainder of the session.
|
Optimized Sham
n=28 Participants
One 20-minute session of active sham in which the Stimweaver optimization algorithm will be used with the objective of creating a null electric field on the target left dlPFC with the constraint that some gel electrodes deliver low-level currents that still induce cutaneous sensations.
|
|---|---|---|---|---|
|
Absolute Change in Single Task Postural Sway Area From Baseline to Immediately Post Intervention
|
0.0049 m²
Standard Deviation 0.023
|
-0.001 m²
Standard Deviation 0.021
|
0.0025 m²
Standard Deviation 0.012
|
0.01 m²
Standard Deviation 0.023
|
SECONDARY outcome
Timeframe: Change from baseline to immediately post-tDCS, up to 60 minutesPostural sway area was assessed by measuring postural sway elliptical area during two, 45-second trials of standing with eyes open while performing a cognitive task (dual task) on a stationary force platform (Kistler, Amherst, NY) pre and post intervention. The cognitive task was verbalized serial subtractions of 3's from a random three-digit number between 200 and 999. Participant responses during each trial were recorded. The absolute change from baseline to immediately post intervention was calculated by averaging the dual task postural sway area pre and post.
Outcome measures
| Measure |
Conventional tDCS
n=29 Participants
One 20-minute session of active tDCS using two 35 cm2 sponge electrodes targeting the left dlPFC.
|
Optimized tDCS
n=29 Participants
One 20-minute session of active tDCS using two 35 cm2 sponge electrodes targeting the left dlPFC.
|
Conventional Sham
n=29 Participants
One 20-minute session of inactive sham tDCS delivered via two sponge electrodes for a short period of time before it is ramped down to zero for the remainder of the session.
|
Optimized Sham
n=28 Participants
One 20-minute session of active sham in which the Stimweaver optimization algorithm will be used with the objective of creating a null electric field on the target left dlPFC with the constraint that some gel electrodes deliver low-level currents that still induce cutaneous sensations.
|
|---|---|---|---|---|
|
Absolute Change in Dual Task Postural Sway Area From Baseline to Immediately Post Intervention
|
-0.0081 m²
Standard Deviation 0.041
|
-0.0091 m²
Standard Deviation 0.034
|
0.0025 m²
Standard Deviation 0.029
|
0.0086 m²
Standard Deviation 0.021
|
Adverse Events
Conventional tDCS
Optimized tDCS
Conventional Sham
Optimized Sham
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Conventional tDCS
n=29 participants at risk
One 20-minute session of active tDCS using two 35 cm2 sponge electrodes targeting the left dlPFC.
|
Optimized tDCS
n=29 participants at risk
One 20-minute session of active tDCS using eight gel electrodes with placement and current parameters optimized to the cohort targeting the left dlPFC.
|
Conventional Sham
n=29 participants at risk
One 20-minute session of inactive sham tDCS delivered via two sponge electrodes for a short period of time before it is ramped down to zero for the remainder of the session.
|
Optimized Sham
n=28 participants at risk
One 20-minute session of active sham in which the Stimweaver optimization algorithm will be used with the objective of creating a null electric field on the target left dlPFC with the constraint that some gel electrodes deliver low-level currents that still induce cutaneous sensations.
|
|---|---|---|---|---|
|
Vascular disorders
Dizziness
|
0.00%
0/29 • 8 weeks
|
3.4%
1/29 • Number of events 1 • 8 weeks
|
3.4%
1/29 • Number of events 1 • 8 weeks
|
0.00%
0/28 • 8 weeks
|
|
Injury, poisoning and procedural complications
Fall
|
0.00%
0/29 • 8 weeks
|
0.00%
0/29 • 8 weeks
|
3.4%
1/29 • Number of events 1 • 8 weeks
|
0.00%
0/28 • 8 weeks
|
|
Investigations
Blood iron decreased
|
3.4%
1/29 • Number of events 1 • 8 weeks
|
0.00%
0/29 • 8 weeks
|
0.00%
0/29 • 8 weeks
|
0.00%
0/28 • 8 weeks
|
|
Injury, poisoning and procedural complications
Muscle strain
|
0.00%
0/29 • 8 weeks
|
0.00%
0/29 • 8 weeks
|
3.4%
1/29 • Number of events 1 • 8 weeks
|
3.6%
1/28 • Number of events 1 • 8 weeks
|
|
Nervous system disorders
Headache
|
0.00%
0/29 • 8 weeks
|
0.00%
0/29 • 8 weeks
|
3.4%
1/29 • Number of events 1 • 8 weeks
|
3.6%
1/28 • Number of events 1 • 8 weeks
|
|
Musculoskeletal and connective tissue disorders
Arthralgia
|
0.00%
0/29 • 8 weeks
|
0.00%
0/29 • 8 weeks
|
0.00%
0/29 • 8 weeks
|
3.6%
1/28 • Number of events 1 • 8 weeks
|
|
Musculoskeletal and connective tissue disorders
Muscle spasms
|
0.00%
0/29 • 8 weeks
|
0.00%
0/29 • 8 weeks
|
0.00%
0/29 • 8 weeks
|
3.6%
1/28 • Number of events 1 • 8 weeks
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place